Google Chrome
Safari
Firefox
Edge
Press Clipping / Sep 23, 2020
Hovione to support production of antiviral Veklury for COVID-19
Manufacturing Chemist, September 23, 2020
Search
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Article / Feb 25, 2016
Continuous Processing: Meeting the Need for New Manufacturing Strategies
Published in Pharma’s Almanac, February 2016
Press Release / Aug 23, 2022
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Article / Aug 30, 2016
Accelerating approval and reducing costs of spray dried drugs through development by design
Pharma's Almanac, Global Pharmaceutical Supply Chain Trends, Q3 2016
Press Clipping / Dec 10, 2018
Life Sciences: Hovione increases production capacity while looking forward to its tenth year in Cork
Irish Examiner, December 10, 2018
Article / Apr 01, 2017
PAT for Continuous API Manufacturing Progresses
Advances in process analytical technology have been achieved, but significant challenges remain
Press Clipping / Sep 23, 2020
Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million
Business Wire, September 23, 2020
Press Release / Feb 22, 2022
Hovione and Zerion Pharma announce a strategic partnership to market the Dispersome® technology platform
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.